Impact of CD19 CAR T‐Cell Therapy on Pathogen‐Specific Antibody Titers in Lymphoma Patients
Transplant Infectious Disease · 2026
DOI: 10.1111/tid.70188 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2026. Verfasst von Hayley Foy-Stones und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cryobiology Laboratory Stem Cell Facility, St. James's Hospital, Dublin, Ireland. Hauptthemen laut MEDLINE: Antigens, CD19, Antibodies, Viral, Antibodies, Bacterial, Lymphoma. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
CD19‐directed chimeric antigen receptor (CAR) T‐cell therapy has exhibited efficacy in treating relapsed/refractory high‐grade B‐cell malignancies, but off‐tumor effects cause prolonged hypogammaglobulinemia and B‐cell aplasia. Limited data exist on pathogen‐specific IgG titers post‐CD19 CAR T‐cell therapy.
Methods
We evaluated the impact of CD19 CAR T‐cell therapy on vaccine‐preventable infectious disease IgG titers in 20 patients to assess humoral immunity. IgG titers for measles virus (MeV), mumps virus (MuV), rubella virus (RuV), varicella zoster virus (VZV), pneumococcal capsular polysaccharide, Haemophilus influenzae type B (Hib), and tetanus toxoid were measured at baseline and Day 100 post‐CD19 CAR T‐cell therapy.
Results
Seropositivity for all pathogens remained stable from baseline to Day 100. Quantitative IgG titers for MeV, MuV, RuV, VZV, and tetanus also remained stable. Median pneumococcal IgG and Hib IgG titers declined ( p < 0.05); however, no arbitrary fourfold decreases were observed. Median total IgG concentrations declined ( p < 0.05).
Conclusion
MeV, MuV, RuV, VZV, and tetanus toxoid IgG remained stable following CD19 CAR T‐cell therapy, while pneumococcal and Hib IgG titers showed marginal quantitative declines, without any fourfold reductions. Overall, humoral immunity at Day 100 following CD19 CAR T‐cell therapy remained largely preserved. These seroprevalence findings suggest that routine revaccination may not be required in our patient cohort and highlight the importance of patient monitoring to inform revaccination decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cryobiology Laboratory Stem Cell Facility, St. James's Hospital, Dublin, Ireland.
- Trinity Translational Medicine Institute, Trinity College, Dublin, Ireland.
- National Adult Stem Cell Transplant and Adult CAR T-Cell Programme, Haematology, St. James's Hospital, Dublin, Ireland.
- Irish Blood Transfusion Service, Dublin, Ireland.
- Department of Clinical Science, University of Bergen, Bergen, Norway.
- UCD School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.
ORCID-Profile: Hayley Foy-Stones, Nicola Gardiner, Nina Orfali, Allison Waters
Zitieren
APA
Foy-Stones, H., Gardiner, N., Walsh, E., Doherty, D. G., McElligott, A. M., Armstrong, C., Orfali, N., Henderson, R., Vandenberghe, E., Higgins, E., Hervig, T., Waters, A., Crowley, B., Groarke, E., Conlon, N. P., & Bacon, C. L. (2026). Impact of CD19 CAR T‐Cell Therapy on Pathogen‐Specific Antibody Titers in Lymphoma Patients. Transplant Infectious Disease. https://doi.org/10.1111/tid.70188
Vancouver
Foy-Stones H, Gardiner N, Walsh E, Doherty DG, McElligott AM, Armstrong C, et al. Impact of CD19 CAR T‐Cell Therapy on Pathogen‐Specific Antibody Titers in Lymphoma Patients. Transplant Infectious Disease. 2026. doi:10.1111/tid.70188
BibTeX
@article{FoyStones2026,
author = {Foy-Stones, Hayley and Gardiner, Nicola and Walsh, Ellen and Doherty, Derek G and McElligott, Anthony M and Armstrong, Chris and Orfali, Nina and Henderson, Robert and Vandenberghe, Elisabeth and Higgins, Elizabeth and Hervig, Tor and Waters, Allison and Crowley, Brendan and Groarke, Elizabeth and Conlon, Niall P and Bacon, Christopher L},
title = {Impact of CD19 CAR T‐Cell Therapy on Pathogen‐Specific Antibody Titers in Lymphoma Patients},
journal = {Transplant Infectious Disease},
year = {2026},
doi = {10.1111/tid.70188}
}
EUVIMED